Quantzig’s Real-World Analytics Study Helped an API Manufacturing Company to Improve Patient Outcomes – Request Proposal Now!
LONDON--(BUSINESS WIRE)--Aug 3, 2018--Quantzig, a pure-play analytics solutions provider, has announced the completion of their latest . An active pharmaceutical ingredient manufacturing company wanted to compare the patient outcomes and benchmark the cost of their API drug formulations against their competitors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180803005274/en/
REAL WORLD ANALYTICS STUDY FOR AN API MANUFACTURING COMPANY (Graphic: Business Wire)
According to the pharmaceutical industry experts at , “The rising occurrence of chronic diseases is expected to drive the growth of the global API market in the coming years.”
Active pharmaceutical ingredient, or API, is the most crucial part of new pharmaceutical drug formulations and has therapeutic effects on the body. The recent increase in chronic diseases is going to drive the growth of the global API market in the coming years.
The real world evidence analytics solution helped the client to identify the effect of their drug formulations and better gauge patient outcomes. The pharma company was also able to develop a platform to accumulate patient data from several sources.
This real-world evidence analytics solution provided benefits that helped the client to:Analyze the cost and outcomes associated with different treatment pathways Gain actionable insights to boost business growth To know more about the benefits of real-world evidence analytics,
This real-world evidence analytics solution offered predictive insights on:Enhancing patient outcomes through improved drug formulations Gaining a stronger foothold in the API market To gain detail insights and understand the scope of our research,
View the complete real-world evidence analytics study here:
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on all of Quantzig’s services and the solutions they have provided to Fortune 500 clients across all industries, please contact us.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180803005274/en/
US: +1 630 538 7144
UK: +44 208 629 1455
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
Copyright Business Wire 2018.
PUB: 08/03/2018 08:57 AM/DISC: 08/03/2018 08:57 AM